Which has grown faster, BMY or GILD?

Over the past five years, GILD grew revenue faster — BMY at a 2.08% CAGR versus GILD at 2.72%.

Does BMY or GILD pay a bigger dividend?

BMY yields 3.94% and GILD yields 2.22% based on trailing dividends and the latest price.

Is BMY or GILD more profitable?

BMY runs the higher net margin — BMY at 18.87% versus GILD at -10.64%.

How have BMY and GILD total returns compared?

Over the past 10 years, BMY delivered 5.01% and GILD delivered 10.21% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Gilead Sciences, Inc. (GILD)

A side-by-side comparison of Bristol-Myers Squibb Company and Gilead Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$130.00B

$63.64HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

GILD

Gilead Sciences, Inc.

$178.44B

$143.72HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — BMY vs GILD

growth of $100 · dividends reinvested · last 10y

BMY +64.7% (+5.1%/yr)GILD +161.3% (+10.1%/yr)GILD compounded faster over this window

BMY GILD

BMY vs GILD: by the numbers

•GILD is the larger company ($178.44B vs $130.00B market cap).
•BMY is profitable (18.87% net margin) while GILD runs a net loss (-10.64%).
•GILD grew revenue faster over the past five years (2.72% vs 2.08% CAGR).
•BMY pays the higher dividend yield (3.94% vs 2.22%).

Metrics side by side

Valuation

Metric	BMY	GILD
P/E ratio	14.02	N/A
Forward P/E	9.18	N/A
P/S ratio	2.64	5.86
P/B ratio	5.82	15.09
EV / EBITDA	9.71	N/A
FCF yield	8.80%	7.27%

Profitability

Metric	BMY	GILD
Gross margin	70.16%	79.59%
Operating margin	28.27%	39.74%
Net margin	18.87%	-10.64%
ROE	41.59%	-27.39%
ROIC	15.47%	-3.66%

Dividends

Metric	BMY	GILD
Dividend yield	3.94%	2.22%
Payout ratio	55.29%	N/A

Growth (annualized)

Metric	BMY	GILD
Revenue CAGR (5Y)	2.08%	2.72%
EPS CAGR (5Y)	9.38%	133.83%
FCF CAGR (5Y)	-0.95%	9.27%
Total return CAGR (5Y)	4.39%	19.60%

Frequently asked

Which has grown faster, BMY or GILD?: Over the past five years, GILD grew revenue faster — BMY at a 2.08% CAGR versus GILD at 2.72%.
Does BMY or GILD pay a bigger dividend?: BMY yields 3.94% and GILD yields 2.22% based on trailing dividends and the latest price.
Is BMY or GILD more profitable?: BMY runs the higher net margin — BMY at 18.87% versus GILD at -10.64%.
How have BMY and GILD total returns compared?: Over the past 10 years, BMY delivered 5.01% and GILD delivered 10.21% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full GILD analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Bristol-Myers Squibb dividend yield Gilead Sciences dividend yield Bristol-Myers Squibb ROE Gilead Sciences ROE Bristol-Myers Squibb operating margin Gilead Sciences operating margin Bristol-Myers Squibb revenue growth Gilead Sciences revenue growth Bristol-Myers Squibb free cash flow Gilead Sciences free cash flow

Bristol-Myers Squibb & Gilead Sciences appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.